Home›People›Gina Chapman
GC

Gina Chapman

Director at Entrada Therapeutics. Also a chief executive officer and director at CARGO Therapeutics.

ExecutiveDirectorPublic company
Updated Oct 27, 2026·Latest SEC filing Jun 12, 2026·Suggest an edit

About Gina Chapman

Gina Chapman is a director at Entrada Therapeutics.

Form D filings name Gina Chapman as a chief executive officer and director at CARGO Therapeutics.

Gina Chapman reports to the SEC as a director or officer of 2 public companies, including CARGO Therapeutics (CRGX).

Gina Chapman first appears on SEC filings in 2023.

Experience

This experience comes from SEC filings. The years are when the filings name Gina Chapman in the role, so the role may have started earlier or lasted longer.

Entrada Therapeutics, Inc.
Director
2023 – 2026 · Public company (TRDA)
CARGO Therapeutics, Inc.
President & CEO, director
2023 – 2025 · Public company (CRGX)

Key Colleagues at Startups

The people Gina Chapman works with at each company, as listed on that company's latest Form D.

CARGO Therapeutics, Inc. · Form D, Mar 1, 2023
AB
JW
CM
HL
JO
John Orwin
Director
AR
Anup Radhakrishnan
Executive officer

Sources

  1. SECCARGO Therapeutics, Inc. Form D, filed Mar 1, 2023
  2. SECForms 3, 4 and 5 filed by Gina Chapman (SEC filer 1989220)